mortality rate
[대역어] 사망률
[용어속성] Term
[용어속성] Term
Clinical characteristics of chronic liver disease with coronavirus disease 2019 (COVID-19): a cohort study in Wuhan, China
Research Paper
[키워드] 95% CI
Acute liver injury
Analysis
analyzed
average
Care
Characteristics
chronic liver disease
CLD
clinical
Clinical characteristics
cohort study
coronavirus disease
correlated
COVID-19
COVID-19 patient
COVID-19 patients
COX
deaths
described
diagnosed
enrolled
expression
In-hospital
Increased
independent
independent risk factor
Jin
Liver injury
LOS
Mortality
mortality rate
mortality risk
Neutrophil-to-lymphocyte ratio
NLR
outcome
Patient
patients
Pneumonia
poor prognosis
Regression model
relative
retrospective cohort study
severity
significantly
suffered
suggested
survival
was performed
Wuhan
Wuhan, China
[DOI] 10.18632/aging.103632 PMC 바로가기 [Article Type] Research Paper
[DOI] 10.18632/aging.103632 PMC 바로가기 [Article Type] Research Paper
Practical Recommendations for Maintaining Active Lifestyle during the COVID-19 Pandemic: A Systematic Literature Review
Review
[키워드] Adults
article
consequence
COVID-19
database
diminished
effort
Evidence
General population
Health
information
international organization
Isolation
less
literature
maintain
maintaining
medium
Methodological quality
Mild
moderate
mortality rate
Older
pandemic
Pandemics
physical activity
physical activity level
Population
provided
quarantine
ranged
recommendation
recommendations
reduce
reduced
Region
Relaxation technique
reported
Research
researchers
review
Safe
screened
social isolation
stress levels
systematic review
Volume
Web of Science
were used
[DOI] 10.3390/ijerph17176265 PMC 바로가기 [Article Type] Review
[DOI] 10.3390/ijerph17176265 PMC 바로가기 [Article Type] Review
Cardiac Injury and Clinical Course of Patients With Coronavirus Disease 2019
Cardiovascular Medicine
[키워드] 95% confidence interval
adjusted hazard ratio
Admission
advanced age
Analysis
cardiac
cardiac injury
checked
clinical
Clinical course
Clinical data
Cohort
complicate
Complication
Coronary artery disease
coronavirus disease
correlated
Course
COVID-19
Critical
d -dimer
demographic
disease course
Hospitalization
hospitalized patient
hypoxia
increase
Infection
Inflammatory factor
Inflammatory marker
Injury
Laboratory
Mortality
mortality rate
Patient
patients with COVID-19
potential mechanism
predicted
Predictive
receiver operating characteristic
resulting
selected
sensitivity
severe patients
specificity
suffered
the disease
troponin
Ventilation
with COVID-19
Wuhan
[DOI] 10.3389/fcvm.2020.00147 PMC 바로가기 [Article Type] Cardiovascular Medicine
[DOI] 10.3389/fcvm.2020.00147 PMC 바로가기 [Article Type] Cardiovascular Medicine
Nationwide Results of COVID-19 Contact Tracing in South Korea: Individual Participant Data From an Epidemiological Survey
Original Paper
[키워드] 95% CI
adjusted
affected
calculated
Care
changed
Characteristics
Cluster
confirmed COVID-19 case
Contact tracing
coronavirus
COVID-19
effective
Effectiveness
entire cohort
epidemiological
Epidemiology
evaluate
health data
Inconclusive
individual
Infection
Mortality
mortality rate
objective
participant
Patient
Result
risk
SARS-CoV-2
SARS-CoV-2 transmission
significantly
significantly higher
significantly increased
social distancing
South
South Korea
spread of COVID-19
survey
tested
the epidemic
tracing
Transmission
[DOI] 10.2196/20992 PMC 바로가기 [Article Type] Original Paper
[DOI] 10.2196/20992 PMC 바로가기 [Article Type] Original Paper
A Meta-Analysis on the Effects of Hydroxychloroquine on COVID-19
Internal Medicine
[키워드] acute respiratory syndrome
adhere
adverse effect
Analysis
analyzed
article
Azithromycin
Chloroquine
Clinical outcome
Cochrane Library
control group
coronavirus
COVID-19
disease
disease severity
Effect
effort
eligibility criteria
eligible
exclusion criteria
Google Scholar
greater
group
HCQ
Healthcare professional
Hydroxychloroquine
Inclusion
independent
item
Meta-analysis
Mild
moderate
mortality rate
outcome measure
overall mortality
pandemic
participant
patients with COVID-19
Prevent
public health crisis
Reporting
review
SARS-CoV-2
screened
selected
Side effect
Spread
Symptom
Transmission
treat
treated
treated patient
virus
was performed
WHO
World Health Organization
[DOI] 10.7759/cureus.10005 PMC 바로가기 [Article Type] Internal Medicine
[DOI] 10.7759/cureus.10005 PMC 바로가기 [Article Type] Internal Medicine
Development of early warning and rapid response system for patients with novel coronavirus pneumonia (COVID-19) A research protocol
3900
[키워드] addition
Adult patient
build
caused
Clinical deterioration
cohort study
contagious
Coronavirus disease 2019
COVID-19
COVID-19 patients
Critical
Critical care
Critically ill
Critically ill patient
detect
deteriorate
Deterioration
determine
development
diagnosed with COVID-19
disease
disease severity
driven by
early warning
example
excluded
hospital
Hypothesis
ICU
immunosuppression state
implementation
include
increase
increased risk
Intensive
intensive care
interval
Intervention
lactating
medical resource
mortality rate
Novel coronavirus
Nurses
outcome
Patient
patient self-reporting
patients
Physicians
Pneumonia
pregnant
Primary outcome
problems
proportion
prospective cohort study
provide
public health
rapid response
recommendations
recruited
required
Research
Research protocol
risk
secondary
significantly
transfer
Treatment
Vaccine
[DOI] 10.1097/MD.0000000000021874 PMC 바로가기 [Article Type] 3900
[DOI] 10.1097/MD.0000000000021874 PMC 바로가기 [Article Type] 3900
Timing social distancing to avert unmanageable COVID-19 hospital surges
403
[키워드] adopted
age
America
center
cocooning
Control
coronavirus disease
COVID-19
death
develop
example
expected
force
healthcare
hospital
Hospital admission
increase
independent
lack
Local
lockdown
mathematical
mitigate
modulating
mortality rate
opening
optimization
pandemic
Population
prevention
Public health response
risk
risk of infection
robust
School
Significance
social distancing
Social distancing measure
The United States
threshold
Transmission
Trigger
triggered
triggering
White House
[DOI] 10.1073/pnas.2009033117 PMC 바로가기 [Article Type] 403
[DOI] 10.1073/pnas.2009033117 PMC 바로가기 [Article Type] 403
Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells
인간 탯줄 중간엽 줄기세포로 중증 코로나19 치료
Research
[키워드] 28-day mortality
C-reactive protein
cell infusion
change
Chinese
clinical
Clinical characteristics
Clinical improvement
clinical symptom
Clinical symptoms
control group
Coronavirus disease-19 (COVID-19)
Coronavirus pneumonia
COVID-19
Critical
critical condition
Critical illness
CRP
determine
died
effective
faster
fatigue
hematologic
Human umbilical cord mesenchymal stem cells
IL-6
IL-6 level
IL-6 levels
incidence
infusion
interleukin
interleukin 6
invasive
invasive ventilation
Lung inflammation
lymphocyte
Lymphocyte count
measurement
mesenchymal stem cell
mortality rate
MSCs
normal range
objective
oxygen
oxygen saturation
Patient
progression
randomly divided
reached
respiratory
Respiratory disease
Safe
severe COVID-19
Shortness of breath
significant difference
significantly
significantly lower
significantly shorter
standard treatment
stem cell
Symptom
Therapeutics
Treatment
treatment group
two groups
umbilical
Umbilical cord
weakness
[DOI] 10.1186/s13287-020-01875-5 PMC 바로가기 [Article Type] Research
[DOI] 10.1186/s13287-020-01875-5 PMC 바로가기 [Article Type] Research
Multi-centre, three arm, randomized controlled trial on the use of methylprednisolone and unfractionated heparin in critically ill ventilated patients with pneumonia from SARS-CoV-2 infection: A structured summary of a study protocol for a randomised controlled trial
Letter
[키워드] 24 hour
absolute reduction
Administered
administration
AIFA
airway
allocation sequence
Alpha
Anticoagulant
anticoagulant therapy
Anticoagulant treatment
approval
Arm
Aspergillus
assigned
assumption
average
bleeding
bleeding event
blinded
Block randomisation
block size
BMI
Brain
Breastfeeding
Candida
checked
childbearing age
chronic
clinical
clinical condition
clinically
combined use
conjunctival
contributed
corpus
Corticosteroid
COVID-19
criteria
Critical
Critically ill
cytomegalovirus
D-dimer level
death
defined
Delay
detect
diagnostic
discharge
dissemination
dosage
drug
dysfunction
effective
element
eligible patient
enoxaparin
enrolled
EudraCT
exclusion criteria
expected
hematemesis
hematoma
heparin-induced thrombocytopenia
Herpe
high risk
High-dose
history
hospital
hospital discharge
Hypothesis
ICU
ICU free day
ICU Patients
impairing
Inclusion
inclusion criteria
indicated
Infection
initial
Inpatient
intensive care unit
interval
Intervention
Intra-articular
intramuscular
intravenously
invasive
Invasive mechanical ventilation
investigator
Italian
limit
LMWH
low molecular weight
low-molecular weight heparin
macroscopic
major bleeding
mechanical ventilation
medical intervention
Methylprednisolone
Mortality
mortality rate
Myocardial
Non-invasive
non-invasive ventilation
number
objective
occur
ophthalmic
organ dysfunction
PaO
parallel group
participant
Patient
performed
Pharyngeal swab
Pneumonia
positive
positive pressure
pregnancy test
Presence
Prophylactic
prophylactic dose
Prophylaxis
protocol
random
randomisation
randomised
randomised controlled trial
randomization
Randomized
Randomized controlled trial
Randomly
Ratio
receive
recent
recruited
recruitment
Rectal Bleeding
red blood cell
reduce
reducing
Registered
required
risk of death
Safety
Sample size
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 pneumonia
secondary
secure
severe disease
sick
significantly
sodium
status
steroid
stratified
stroke
study drug
Study protocol
subcutaneously
surgical
syndrome
therapeutic
therapeutic doses
therapy
Treatment
treatment group
unfractionated heparin
Venous Thromboembolism
ventilated patient
Ventilation
website
Weighting
Withdrawal
women
[DOI] 10.1186/s13063-020-04645-z PMC 바로가기 [Article Type] Letter
[DOI] 10.1186/s13063-020-04645-z PMC 바로가기 [Article Type] Letter